Ocular Therapeutix plans wet AMD drug filing for late 2026

Go back to Ocular Therapeutix plans wet AMD drug filing for late 2026
(NASDAQ: OCUL) Delayed: 10.20 +0.06 (0.59%)
Previous Close $10.14    52 Week High $14.50 
Open $10.15    52 Week Low $4.04 
Day High $10.26    P/E N/A 
Day Low $10.02    EPS $0.00 
Volume 349,268